Kendall Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$623K Sell
28,560
-6,170
-18% -$180K 0.1% 153
2026
Q2
$1.26M Buy
34,730
+18,465
+114% +$631K 0.21% 111
2026
Q1
$538K Sell
16,265
-325
-2% -$13.8K 0.11% 153
2025
Q4
$768K Sell
16,590
-1,390
-8% -$58.2K 0.16% 132
2025
Q3
$629K Hold
17,980
– – 0.14% 138
2025
Q2
$532K Sell
17,980
-2,380
-12% -$67.9K 0.14% 144
2025
Q1
$608K Buy
20,360
+2,600
+15% +$79.5K 0.18% 134
2024
Q4
$509K Buy
17,760
+4,260
+32% +$141K 0.15% 147
2024
Q3
$522K Buy
+13,500
New +$481K 0.16% 144

Other funds holding COLL

Kendall Capital Management's COLL Position: Q3 2026 in Review

Kendall Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 18% in Q3 2026, selling an estimated $180K and leaving 28,560 shares worth $623K. The position accounts for 0.1% of the portfolio, ranked #153.

Kendall Capital Management first reported a position in COLL in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q2 2026. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Kendall Capital Management held 28,560 shares of Collegium Pharmaceutical worth $623K as of Q3 2026.
  • Kendall Capital Management sold 6,170 Collegium Pharmaceutical shares in Q3 2026, an estimated $180K.
  • Collegium Pharmaceutical made up 0.1% of Kendall Capital Management's portfolio in Q3 2026, its #153 holding.
  • Kendall Capital Management first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
  • Kendall Capital Management's Collegium Pharmaceutical position peaked at $1.26M in Q2 2026.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Kendall Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.